For example, ACS’ recommendation differs from the draft USPSTF recommendation on breast cancer screening released earlier this year. The USPSTF recommends biennial screening mammography for women ages 50 to 74 years (Grade B recommendation). For women ages 40 to 49 years, the Task Force determined that the decision should be made individually (Grade C recommendation).
Given the varying recommendations, clinicians play a crucial role in conveying key messages on benefits and harms of breast cancer screening and engaging patients in shared decision-making.
For more information on breast cancer screening recommendations and their potential impact on patients’ access to mammography, contact Minnie Song at email@example.com.